Editorial
Open Access
Editorial for Oncology Communications: Integrating Innovation for Transformative Cancer Care
1
Department of General Surgery, the Second Xiangya Hospital of Central South University, Changsha, China
2
Clinical Research Center for Breast Disease In Hunan Province, Changsha, 410011, China
3
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
* Corresponding Author:
Wenjun Yi,
[email protected]
Volume 1, Issue 1
2026
Received: 24 September 2025
Accepted: 22 October 2025
Published: 03 November 2025
Article Information
Abstract
This editorial mainly states the meaning of creating the Oncology Communications and highlights the importance and outlook of integrative medicine. We stress the importance of multidisciplinary, interdisciplinary, and cross-disciplinary collaboration, encouraging oncologists to work closely with experts from various fields, including basic medicine, mathematics, physics, sociology, artificial intelligence, and materials science. This collaboration aims to clarify the mechanisms of tumor development and progression, identify novel therapeutic targets, promote clinical translation, and ultimately benefit patients.
Keywords
oncology
integrative medicine
translational research
multidisciplinary collaboration
Data Availability Statement
Not applicable.
Funding
This study was supported by the National Natural Science Foundation of China under Grant 82403073, and the Innovation Platform and Talent Plan of Hunan Province under Grant 2023SK4019.
Conflicts of Interest
The authors declare no conflicts of interest.
Ethical Approval and Consent to Participate
Not applicable.
References
- Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263.
[CrossRef] [Google Scholar] - Montegut, L., Lopez-Otin, C., & Kroemer, G. (2024). Aging and cancer. Molecular Cancer, 23(1), 106.
[CrossRef] [Google Scholar] - Wagle, N. S., Nogueira, L., Devasia, T. P., Mariotto, A. B., Yabroff, K. R., Islami, F., ... & Siegel, R. L. (2025). Cancer treatment and survivorship statistics, 2025. CA: A Cancer Journal for Clinicians.
[CrossRef] [Google Scholar] - Gao, L., Huang, S., Zhang, H., & Wang, X. (2021). Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resistance Updates, 57, 100770.
[CrossRef] [Google Scholar] - Bradley, C. J., Yabroff, K. R., Mariotto, A. B., & Ganz, P. A. (2022). Policies and Practices to Address Cancer's Long-Term Adverse Consequences. Journal of the National Cancer Institute, 114(8), 1065–1071.
[CrossRef] [Google Scholar] - Yip, H. F., Zhang, Z., Li, T., & Lu, A. (2025). Large Language Models in Integrative Medicine: Progress, Challenges, and Opportunities. Journal of Evidence-Based Medicine, 18(2), e70031.
[CrossRef] [Google Scholar] - Lopez, G., Mao, J. J., & Cohen, L. (2017). Integrative Oncology. Medical Clinics of North America, 101(5), 977–985.
[CrossRef] [Google Scholar] - Mao, J. J., Pillai, G. G., Andrade, C. J., Ligibel, J. A., Basu, P., Cohen, L., ... & Salicrup, L. A. (2022). Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA: a cancer journal for clinicians, 72(2), 144-164.
[CrossRef] [Google Scholar] - Bower, J. E., Lacchetti, C., Alici, Y., Barton, D. L., Bruner, D., Canin, B. E., ... & Mustian, K. (2024). Management of fatigue in adult survivors of cancer: ASCO–Society for Integrative Oncology guideline update. Journal of Clinical Oncology, 42(20), 2456-2487.
[CrossRef] [Google Scholar] - Carlson, L. E., Ismaila, N., Addington, E. L., Asher, G. N., Atreya, C., Balneaves, L. G., ... & Rowland, J. H. (2023). Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for Integrative Oncology–ASCO Guideline. Journal of Clinical Oncology, 41(28), 4562-4591.
[CrossRef] [Google Scholar] - Wang, Y., Zhang, Q., Smith, J., & Johnson, A. B. (2025). Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer. Experimental Hematology & Oncology, 14(1), 114.
[CrossRef] [Google Scholar] - Mandal, K., Barik, G. K., & Santra, M. K. (2025). Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions. Molecular Cancer, 24(1), 1-52.
[CrossRef] [Google Scholar] - Tian, B., Yang, Y., Kuang, S., Piao, M., Li, C., Zhao, H., & Wang, H. (2025). Current status of management of immune-related adverse events and practical needs for oncologist education. Cancer Biology & Medicine.
[CrossRef] [Google Scholar] - Lotter, W., Hassett, M. J., Schultz, N., Kehl, K. L., Van Allen, E. M., & Cerami, E. (2024). Artificial intelligence in oncology: current landscape, challenges, and future directions. Cancer discovery, 14(5), 711-726.
[CrossRef] [Google Scholar] - Kolla, L., & Parikh, R. B. (2024). Uses and limitations of artificial intelligence for oncology. Cancer, 130(12), 2101-2107.
[CrossRef] [Google Scholar] - He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2023, January). Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. In Seminars in Cancer Biology (Vol. 88, pp. 187-200). Academic Press.
[CrossRef] [Google Scholar] - McCombie, W. R., McPherson, J. D., & Mardis, E. R. (2019). Next-generation sequencing technologies. Cold Spring Harbor perspectives in medicine, 9(11), a036798.
[CrossRef] [Google Scholar] - Kumar, K. R., Cowley, M. J., & Davis, R. L. (2024, October). Next-generation sequencing and emerging technologies. In Seminars in thrombosis and hemostasis (Vol. 50, No. 07, pp. 1026-1038). Thieme Medical Publishers.
[CrossRef] [Google Scholar] - Mohd Zuhdi, N. F., Siddig, A., Mohd Nafi, S. N., Md Salleh, M. S., Yahya, M. M., Wan Zain, W. Z., ... & Wan Abdul Rahman, W. F. (2025). Next-generation sequencing in breast cancer: current clinical applications and future directions. Annals of Medicine, 57(1), 2569989.
[CrossRef] [Google Scholar] - Hardwick, S. A., Deveson, I. W., & Mercer, T. R. (2017). Reference standards for next-generation sequencing. Nature Reviews Genetics, 18(8), 473–484.
[CrossRef] [Google Scholar]
Cite This Article
APA Style
Long, Q., Zheng, S., & Yi, W. (2025). Editorial for Oncology Communications: Integrating Innovation for Transformative Cancer Care. Oncology Communications, 1(1), 1–4. https://doi.org/10.62762/OC.2025.363963
Export Citation
RIS Format
Compatible with EndNote, Zotero, Mendeley, and other reference managers
TY - JOUR AU - Long, Qian AU - Zheng, Shaoquan AU - Yi, Wenjun PY - 2025 DA - 2025/11/03 TI - Editorial for Oncology Communications: Integrating Innovation for Transformative Cancer Care JO - Oncology Communications T2 - Oncology Communications JF - Oncology Communications VL - 1 IS - 1 SP - 1 EP - 4 DO - 10.62762/OC.2025.363963 UR - https://www.icck.org/article/abs/OC.2025.363963 KW - oncology KW - integrative medicine KW - translational research KW - multidisciplinary collaboration AB - This editorial mainly states the meaning of creating the Oncology Communications and highlights the importance and outlook of integrative medicine. We stress the importance of multidisciplinary, interdisciplinary, and cross-disciplinary collaboration, encouraging oncologists to work closely with experts from various fields, including basic medicine, mathematics, physics, sociology, artificial intelligence, and materials science. This collaboration aims to clarify the mechanisms of tumor development and progression, identify novel therapeutic targets, promote clinical translation, and ultimately benefit patients. SN - 3142-8894 PB - Institute of Central Computation and Knowledge LA - English ER -
BibTeX Format
Compatible with LaTeX, BibTeX, and other reference managers
@article{Long2025Editorial,
author = {Qian Long and Shaoquan Zheng and Wenjun Yi},
title = {Editorial for Oncology Communications: Integrating Innovation for Transformative Cancer Care},
journal = {Oncology Communications},
year = {2025},
volume = {1},
number = {1},
pages = {1-4},
doi = {10.62762/OC.2025.363963},
url = {https://www.icck.org/article/abs/OC.2025.363963},
abstract = {This editorial mainly states the meaning of creating the Oncology Communications and highlights the importance and outlook of integrative medicine. We stress the importance of multidisciplinary, interdisciplinary, and cross-disciplinary collaboration, encouraging oncologists to work closely with experts from various fields, including basic medicine, mathematics, physics, sociology, artificial intelligence, and materials science. This collaboration aims to clarify the mechanisms of tumor development and progression, identify novel therapeutic targets, promote clinical translation, and ultimately benefit patients.},
keywords = {oncology, integrative medicine, translational research, multidisciplinary collaboration},
issn = {3142-8894},
publisher = {Institute of Central Computation and Knowledge}
}
Publisher's Note
ICCK stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and Permissions
Copyright © 2025 by the Author(s). Published by Institute of Central Computation and Knowledge. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Scan to read this article